US Patent Issued to ALNYLAM PHARMACEUTICALS on March 3 for "ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,653, issued on March 3, was assigned to ALNYLAM PHARMACEUTICALS INC. (Cambridge, Mass.).

"ATAXIN3 (ATXN3) RNAi agent compositions and methods of use thereof" was invented by Adam Castoreno (Framingham, Mass.), Elane Fishilevich (Rochester, Mass.), Jason A. Gilbert (Hingham, Mass.), Charalambos Kaittanis (Cambridge, Mass.), James D. McIninch (Burlington, Mass.), Stuart Milstein (Arlington, Mass.) and Mark K. Schlegel (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to double-stranded ribonucleic acid (dsRNA) agents and compositions targeting the ATXN3 gene, as well as methods of inhibiting expression of an APP g...